N-acetyltransferase 10 (NAT10), the primary writer of N4-acetylcytidine (ac<sup>4</sup>C) on RNA, is broadly upregulated across multiple cancer types and correlates with tumor proliferation, invasion, therapeutic resistance, and poor prognosis, indicating its significant clinical relevance. Here, NAT10 is linked to cancer.